NEW YORK, March 12 – The ability to identify and assess SNPs will help to increase treatment efficacy and reduce adverse drug reactions, helping to save the healthcare industry more than $1 billion over the next decade, a survey released Monday by Front Line Strategic Management Consulting said.

The Foster City, Calif.-based consultancy said that treatment efficacy could increase by 32 percent over current levels while adverse drug reactions could be reduced by up to 25 percent.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Rare gene mutations are guiding the search for drugs to manage chronic pain without opioids, according to CNBC.

The new Francis Crick Institute building can get too noisy for some researchers to concentrate, according to the Guardian.

CBS News reports that there are still many vacancies at the White House Office of Science and Technology Policy, but that it's uncertain whether they will be filled.

In Nucleic Acids Research this week: pipeline to analyze and visualize bacterial genomes, database of global set of human genomes, and more.